mRNA Vaccines Enhance Neutralizing Immunity against SARS-CoV-2 Variants in Convalescent and ChAdOx1-Primed Subjects
To identify the most efficient methods of immunological protection against SARS-CoV-2, including the currently most widespread variants of concern (VOCs)—B.1.1.7, B.1.351 and P.1—a simultaneous side-by-side-comparison of available vaccination regimes is required. In this observational cohort study,...
Những tác giả chính: | , , , , , , , , , , , , , , |
---|---|
Định dạng: | Bài viết |
Ngôn ngữ: | English |
Được phát hành: |
MDPI AG
2021-08-01
|
Loạt: | Vaccines |
Những chủ đề: | |
Truy cập trực tuyến: | https://www.mdpi.com/2076-393X/9/8/918 |